Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Losartan Market Value Analysis: What Growth Lies Ahead Over The Forecast Period?
The losartan market has seen consistent growth in recent years. It is projected to expand from $1.49 billion in 2025 to $1.55 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.2%. This historical growth can be ascribed to factors including the escalating global prevalence of hypertension, broad clinical acceptance of ARBs, an increasing incidence of kidney disease linked to diabetes, heightened awareness regarding cardiovascular risk management, and an early transition from ACE inhibitors to ARBs.
The losartan market is projected to experience consistent expansion over the upcoming years. Its value is anticipated to reach $1.83 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.3%. This anticipated growth during the forecast period stems from factors such as an expanding aging population, an increasing need for antihypertensive medications that protect the kidneys, wider availability of inexpensive generic drugs, a heightened emphasis on preventing strokes, and increased healthcare expenditure for managing chronic diseases. Key trends expected within this period encompass a surge in the prevalence of hypertension and cardiovascular conditions, a developing preference for ARBs over ACE inhibitors, an increase in prescriptions for generic losartan, broader application in managing diabetic nephropathy, and a rise in the adoption of therapies for long-term blood pressure regulation.
Get A Free Sample Report With In-Depth Market Insights:
Losartan Market Growth Factors Behind Sustained Expansion
The increasing occurrence of hypertension is anticipated to fuel the expansion of the losartan market in the future. Hypertension describes a state characterized by consistently elevated blood pressure, potentially increasing the risk of cardiovascular ailments, strokes, and other serious medical issues. The rising frequency of hypertension is associated with diets high in sodium and processed items, contributing to fluid buildup and added stress on the heart. Losartan assists in managing hypertension by inhibiting angiotensin II, a hormone responsible for constricting blood vessels. This action aids in relaxing and dilating these vessels, thereby reducing blood pressure and lessening the strain on the heart. As an illustration, in January 2025, the Centers for Disease Control and Prevention, a US-based organisation, reported that in 2023, high blood pressure was a primary or contributing factor in 664,470 deaths in the United States. Consequently, the expanding prevalence of hypertension is indeed propelling the growth of the losartan market.
Losartan Market Segmentation: How Does The Market Break Down By Category?
The losartan market covered in this report is segmented –
1) By Dosage: Tablet, Powder, Suspension
2) By Source: Contract Manufacturing Organizations, In-House
3) By Distribution Channel: Online, Offline
4) By Application: Hypertension, Stroke, Diabetic Nephropathy, Other Applications
5) By End-User: Adult, Pediatric
Subsegments:
1) By Tablet: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)
2) By Powder: 25 Milligrams (mg), 50 Milligrams (mg), 100 Milligrams (mg)
3) By Suspension: 5 Milligrams (mg) Per 5 Milliliters (mL), 10 Milligrams (mg) Per 5 Milliliters (mL), 25 Milligrams (mg) Per 5 Milliliters (mL)
Losartan Market Industry Trends Fueling Future Revenue Growth
Leading firms within the losartan market are prioritizing the creation of novel products and securing regulatory clearances, particularly for formulations like losartan potassium oral suspension, to improve patient adherence and broaden treatment possibilities. Losartan potassium oral suspension is a liquid version of the losartan potassium drug, specifically designed for patients who encounter difficulties ingesting pills. An example is Scienture Holdings Inc., a biopharmaceutical firm from the US, which obtained Food and Drug Administration (FDA) approval for its product Arbli in March 2025. This formulation is a pre-prepared liquid intended for managing hypertension, reducing stroke risk in hypertensive individuals with left ventricular hypertrophy, and treating diabetic nephropathy in those with type 2 diabetes. It provides accurate dosage without requiring compounding and comes as a 165 mL peppermint-flavored suspension (10 mg/mL), boasting an 18-month shelf life when stored at room temperature.
Losartan Market Competitive Overview And Top Companies
Major companies operating in the losartan market are Viatris Inc., Teva Pharmaceutical Industries Ltd, Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.
View The Full Losartan Market Report:
Losartan Market Geographic Spread And Regional Opportunities
North America was the largest region in the losartan market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the losartan market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
